Copy
See below for a daily digest of the latest Bronchiectasis news!

Bronchiectasis May Increase Risk for Severe COVID-19 Disease

Feb 19, 2021 11:00 am | Patricia Inacio PhD

 

COVID-19 diseaseBronchiectasis might be more frequent in people with severe COVID-19 disease, increasing by over threefold the risk for severe symptoms, according to an analysis of patients in Wuhan, China, where the SARS-CoV-2 virus originated. The study, “Bronchiectasis is one of the indicators of severe coronavirus disease 2019 pneumonia,” was published in the Chinese Medical Journal. […]

The post Bronchiectasis May Increase Risk for Severe COVID-19 Disease appeared first on Bronchiectasis News Today.

Read More
share on Twitter Like Bronchiectasis May Increase Risk for Severe COVID-19 Disease on Facebook

Eurordis Survey: Healthcare Experience Worse for Rare Disease Patients

Feb 18, 2021 08:30 am | Marta Figueiredo

 

People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of an international survey conducted by Eurordis-Rare Diseases Europe. Indeed, rare disease patients overall give their healthcare experience a medium-low rating, of 2.5 on a scale of 1 to 5, the survey results show. The survey […]

The post Eurordis Survey: Healthcare Experience Worse for Rare Disease Patients appeared first on Bronchiectasis News Today.

Read More
share on Twitter Like Eurordis Survey: Healthcare Experience Worse for Rare Disease Patients on Facebook

Tobramycin, Inhaled Antibiotic, Eases Symptoms, Study in Off-label Use Finds

Feb 15, 2021 10:00 am | Steve Bryson PhD

 

tobramycin studyOff-label use of the inhaled antibiotic tobramycin lowered sputum production, and eased shortness of breath, and cough in people with bronchiectasis, a small real-world study found.  Although there was no significant improvement in lung function, the antibiotic eliminated almost half of the reported Pseudomonas aeruginosa infections and led to fewer hospitalizations.  Further studies are necessary […]

The post Tobramycin, Inhaled Antibiotic, Eases Symptoms, Study in Off-label Use Finds appeared first on Bronchiectasis News Today.

Read More
share on Twitter Like Tobramycin, Inhaled Antibiotic, Eases Symptoms, Study in Off-label Use Finds on Facebook

Recent Posts

Electromed Resumes Study of SmartVest
Pandemic Won’t Stop Rare Disease Day on Feb. 28
Chronic Fungi Infection Tied to Poor Outcomes in NTM Lung Disease
CT Scores for Bronchiectasis, Nodules Predict NTM Recurrence
Treatment With Ciprofloxacin Antibiotics Found to Reduce Exacerbations

 


Copyright © 2021 BioNews Services, LLC, All rights reserved.
Email Marketing Powered by Mailchimp
unsubscribe from this list | update subscription preferences